Steve has 20 years of clinical research experience and has spent the majority of that time working within oncology. He is driven to help patients by developing new therapies that improve outcomes. He started his career as a Study Coordinator in the Neuroimaging Center at a McLean Hospital before moving to his first industry position at Genzyme where he worked in various roles within clinical operations and has worked in small biotechs, as well as big pharma. Steve has spent the last 7 years at GSK working as a Clinical Operations Program lead, and helped the team move an asset from a first-in-human trial through numerous phase II and III trials which have resulted in multiple marketing authorizations around the globe within endometrial cancer and dMMR solid tumors. He takes a pragmatic approach while focusing on quality, timely delivery, and efficiency.
